Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Alibaba Group (NYSE:BABA) reported a 75% drop in quarterly profit on Thursday, as heavy investment in artificial intelligence infrastructure squeezed margins at China's e-commerce and cloud giant. Net income for the June quarter fell to 10.4 billion yuan ($1.5 billion), missing analyst...
Berkshire Hathaway (BRK.A) is back in focus after Q2 2026 results combined a sharp jump in net income with the largest share buybacks since 2021, as well as heavy buying of Alphabet and Delta Air Lines. See our latest analysis for Berkshire Hathaway. Berkshire Hathaway’s recent buying spree under Greg Abel and the large Q2 buybacks come as short term share price momentum has softened, with a 7 day share price return of 1.81% decline and a modest year to date share price return of 0.81%, while...
QCOM's diversification gains momentum, but Apple exposure, handset weakness and margin pressure keep the buy case from turning decisive.
The “Mad Money” host remains bullish on a ride-hailing giant, calling it a strong long-term stock
BB's QNX growth, margin gains and raised outlook strengthen its case as APTV faces guidance cuts, launch delays and China auto-market pressure.
Moderna (MRNA) and Merck (MRK) reported promising results in their melanoma vaccine trial, sending the stocks soaring. BD8 Capital Partners CEO and CIO Barbara Doran and Yahoo Finance Markets and Data Editor Jared Blikre chat with Yahoo Finance Executive Editor Brian Sozzi about what the breakthrough could mean for Pfizer (PFE) and the larger healthcare sector.
Nordson stock breaks out to record highs after raising its 2026 guidance with its Q3 beat. Analyst hikes price target on backlog, momentum.
Bitcoin (BTC-USD) surged past $70,000 after Trump met with cryptocurrency leaders at the White House and called on Congress to pass the CLARITY Act. Yahoo Finance Fed Correspondent Jennifer Schonberger reports on who was among the two dozen attendees at the meeting and whether there is real progress on the stalled digital asset legislation.
SPOT's earnings growth, cash flow and expanding monetization support the bull case, but its premium valuation raises the bar for execution.
ALAB is riding surging AI connectivity demand and Scorpio's ramp, while Credo targets over 80% fiscal 2027 growth as its optical portfolio expands.
The NVIDIA GB300 deployment is targeted for early 2027, but financing remains outstanding and Microsoft’s purchase commitments were not disclosed.
Micron rivals are buying back stock at a rapid clip but the American company will have to wait to return capital to shareholders.
Dell Technologies' renewal of its Team Liquid partnership could sharpen Alienware's gaming edge as HP and Corsair expand across premium PCs and peripherals.
WDAY's 62.9% three-month surge reflects strong HCM demand and its AI push, but slower growth, saturation and competition cloud the outlook.
Madison Investments, an investment advisor, released its second-quarter 2026 investor letter for the “Madison Large Cap Fund”. A copy of the letter can be downloaded here. In the second quarter, U.S. stock market indices achieved their best performance since 2020, driven largely by a narrow group of Artificial Intelligence-related stocks. As in the pandemic’s early days, […]
MU nears $1,000 as Apple's China memory stance could boost U.S. chip makers and memory ETFs.
Tetra Tech's $49M NOAA contract expands its coastal resilience work, adding to a string of major deals secured in recent months.
In XRP news today, Ripple has agreed to buy back $750M in shares from employees and early investors, a deal that values the privately held company at roughly $50Bn, up from about $40Bn in November 2025. That makes Ripple worth nearly twice as much as stablecoin issuer Circle, even as ...
A viral JPMorgan chart promises a powerful Q4 surge in midterm election years, but the historical setup it requires looks nothing like what the market has actually done in 2026, and that contradiction has serious implications for anyone counting on a seasonal rescue.
Biotech ETFs are riding a powerful rally fueled by innovation, obesity drugs and M&A, with three funds offering diversified exposure to growth.
FISV trades at a deep valuation discount, but weaker 2026 growth, margin pressure and leverage keep the case for a recovery uncertain.
Deere's Q3 earnings beat estimates as Construction & Forestry and Small Agriculture & Turf strength offset weakness in Production & Precision Agriculture.
SpaceX dominates the headlines and eats up investor attention, but a smaller rocket company keeps quietly racking up wins and landing contracts that suggest the space economy has room for more than one winner.
The S&P 500 Index ($SPX ) (SPY ) is down by -0.20% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.24%. E-mini S&P futures (ESU26 ) are down -0.24%, and September E-mini...
TGT's earnings outlook is improving on stronger sales and traffic, but elevated valuation and execution risks could limit upside.
A landmark trial success for Moderna and Merck's cancer vaccine has strengthened the case for Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the immuno-oncology company developing a rival melanoma treatment, according to one broker covering the sector's innovative small-caps. Merck and...
Best Buy (BBY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MSGE, POWW and HWM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 20th, 2026.
Can we count your visit with Google Analytics? No ads, no profiles. Details
